Price movement over the last 24 hours
AdaptHealth Corp vs YieldMax NVDA Option Income Strategy ETF — how do they compare? AdaptHealth Corp trades at $10.03 (market cap $1.38B), while YieldMax NVDA Option Income Strategy ETF trades at $12.6. The key difference: AdaptHealth Corp is trading nearer its 52-week high, YieldMax NVDA Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals.
| AHCO | NVDY | |
|---|---|---|
Market Cap | $1.38B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $13.38 | $17.96 |
52-Week Low | $8.68 | $12.03 |
Enterprise Value | $3.33B | — |
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.
The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.
NVDY trades at $12.19, up 0.58% on the day, with a bearish technical signal from moving averages but neutral oscillators. The fund generates weekly dividends from its covered call strategy on NVIDIA, with recent payouts ranging from $0.10 to $0.21 per share. News highlights debate whether the income strategy justifies sacrificing NVIDIA's upside potential.
Outlook hinges on NVIDIA's volatility sustaining option premiums; risks include capped gains during NVIDIA rallies. The 1.09% fee and opportunity cost versus direct NVIDIA ownership are key considerations for income-focused investors amid bearish technical trends.
Trailing returns across standard periods
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →NVDY is an actively managed ETF that pursues a synthetic covered call strategy on NVIDIA Corporation (NVDA) stock. The fund primarily sells call options on NVDA and invests in U.S. Treasury securities and other high-quality collateral. Its goal is to generate monthly income from the option premiums. This strategy provides exposure to the high-growth potential of NVDA while seeking to deliver a high yield, though it caps the potential capital appreciation of the stock.
Read more on NVDY →